13 analog-and-mixed-signal PhD positions at Technical University of Munich in Germany
Sort by
Refine Your Search
-
architectures, capable of capturing the structure of complex, high-resolution NMR spectra – analogous to how language models such as ChatGPT learn the structure of human language. One of the primary goals is to
-
seis-mometers, geophones, etc.), as well as in signal processing, High level of communication and teamwork skills, willingness to travel to the Middle East as part of a team, Structured and independent
-
03.06.2025, Wissenschaftliches Personal Chemical signaling, the most ancient and widespread form of communication, plays a crucial role in maintaining species boundaries through exclusive
-
cellular biology, the project will investigate signal transduction mechanisms at the protein and membrane level. Experimental systems will include 2D cell culture, organoid models, and advanced biophysical
-
) or quantitative (e.g., surveys, statistical analysis) methods and demonstrate a willingness to learn about the other approach or mixed-methods research. Knowledge of social science approaches (e.g., psychological
-
decision-making in operational settings, aiming to enhance performance and optimize decision processes. Collaboration opportunities with industry partners are available, providing a strong mix of academic
-
connected by train (ca. 30 minutes), and a perfect starting point to explore the Bavarian Alps and the rest of Germany. Working hours are flexible and remuneration is in accordance with TUM regulations (65
-
indicate when you would be available to start the position. If you are interested in more than one open position in our laboratory, please send only one application and indicate which positions you are
-
of records preferably in English and in a single PDF file, via email to philipp.koehler@tum.de . Please indicate “PhD student in the development of medical sensors” in the subject line. For any question
-
Signals in Cancer” (Head: Prof. Dr. med. Jürgen Ruland) is to (i) explore the molecular mechanisms and pathways that drive immune dysfunction and immunotherapy resistance, (ii) modulate cancer